Getting relief from sexual dysfunction and incontinence caused by menopause

October 10, 2018, The North American Menopause Society

Microablative fractional CO2 lasers are energy-based devices designed to help manage troublesome menopause symptoms such as painful sex, dryness, itching/burning, urinary frequency, and incontinence. Although there is ongoing debate regarding the safety and effectiveness of vaginal laser surgery, a new study suggests that it may be effective, especially after multiple treatments. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS).

Collectively known as the genitourinary syndrome of (GSM), the various genital and urinary problems associated with menopause have created a market for new therapies and treatments to help women regain sexual function and bladder control. Vaginal surgery represents one of the newer and more hotly contested approaches.

In the case of microablative fractional CO2 laser surgery, a series of microscopic laser beams using fractionated energy penetrate the skin to remove old and damaged skin cells, intended to rebuild the vaginal pathway. In this new study, GSM symptoms were evaluated up to12 months after the last laser and compared based on the number of total therapies applied (up to a total of five).

The results of this small, retrospective, non-sham-controlled study demonstrated that this type of was particularly effective in reducing the intensity of dyspareunia (painful sex) and dryness. It further demonstrated that four or five laser therapies may be superior in lowering the intensity of GSM symptoms compared with three laser therapies in both short- and long-term follow-up. Study results are published in the article "Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results."

"This study adds to the literature on vaginal laser for GSM. However, more robust randomized, sham-controlled data are needed, with larger numbers of women, to evaluate long-term safety, benefits, and risks," says Dr. JoAnn Pinkerton, NAMS executive director. "Until more data are available, all treatment options, including lubricants, vaginal moisturizers, and FDA-approved vaginal and systemic hormone therapies, should be discussed with women who suffer from GSM to determine the best option for them."

Explore further: Options for making sex more enjoyable at any age

Related Stories

Options for making sex more enjoyable at any age

October 3, 2018
Women at any age should be able to enjoy sex. Unfortunately, sexual function and comfort often decreases for women during the menopause transition. A presentation at The North American Menopause Society (NAMS) Annual Meeting ...

Why isn't anyone talking about vaginal dryness (or doing anything about it)?

June 20, 2018
It's a common problem that only gets worse during the menopause transition; yet, no one wants to talk about it, and even fewer women are doing anything to correct it. A new study identifies those factors that contribute to ...

Vaginal estradiol tablets outperform moisturizers when treating vulvovaginal problems

May 9, 2018
Sex shouldn't hurt at any age, yet 75% of postmenopausal women report vaginal dryness, and up to 40% report pain with intercourse. A new study reports that vaginal estradiol tablets just might be what's needed to relieve ...

Laser tx aids genitourinary symptoms of menopause

September 23, 2017
(HealthDay)—Use of a fractional carbon dioxide (CO2) laser is a safe and effective treatment for genitourinary symptoms of menopause (GSM), according to a study published online Sept. 7 in Lasers in Surgery and Medicine.

Don't believe the hype on 'vaginal rejuvenation,' FDA says

July 30, 2018
(HealthDay)—Despite their growing popularity, there's no evidence that so-called "vaginal rejuvenation" procedures are either safe or effective, the U.S. Food and Drug Administration warns.

All vaginal estrogens effective for genitourinary sx of menopause

November 12, 2014
(HealthDay)—All vaginal estrogens are effective for women with genitourinary syndrome of menopause, according to a review published online Nov. 5 in Obstetrics & Gynecology.

Recommended for you

One in four U.S. adults sits more than eight hours a day

November 20, 2018
(HealthDay)—Couch Potato Nation: Nearly half of Americans sit for far too many hours a day and don't get any exercise at all, a new study finds.

Sugar-sweetened beverages are harmful to health and may be addictive, researchers suggest

November 20, 2018
Just as we might have guessed, those tasty, sugar-sweetened beverages that increase risk of diabetes and other chronic diseases may actually be addictive. Youth between 13 and 18 years of age who were deprived of sugary drinks ...

Teen personality traits linked to risk of death from any cause 50 years later

November 20, 2018
Personality traits evident as early as the teenage years may be linked to a heightened or lessened risk of death around 50 years later, suggests observational research of 'baby boomers,' published online in the Journal of ...

Emotional abuse may be linked with menopause misery

November 19, 2018
Smoking, obesity and a sedentary lifestyle have long been linked to heightened symptoms of menopause. Now, a study headed by UC San Francisco has identified another factor that may add to menopause torment: an emotionally ...

How AI could help veterinarians code their notes

November 19, 2018
A team led by scientists at the School of Medicine has developed an algorithm that can read the typed-out notes from veterinarians and predict specific diseases that the animal may have.

Bullying and violence at work increases the risk of cardiovascular disease

November 19, 2018
People who are bullied at work or experience violence at work are at higher risk of heart and brain blood vessel problems, including heart attacks and stroke, according to the largest prospective study to investigate the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.